Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: Analysis from the Australian IPF registry

Structural and functional correlations in a large animal model of bleomycin-induced pulmonary fibrosis

15 p | 13 | 3

Docosatetraenoyl LPA is elevated in exhaled breath condensate in idiopathic pulmonary fibrosis

7 p | 11 | 2

Physical activity and activity space in patients with pulmonary fibrosis not prescribed supplemental oxygen

9 p | 5 | 2

Change in forced vital capacity and associated subsequent outcomes in patients with newly diagnosed idiopathic pulmonary fibrosis

13 p | 10 | 2

Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases

9 p | 11 | 2

Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF)

13 p | 9 | 2

Efficacy, safety, and tolerability of combined pirfenidone and N-acetylcysteine therapy: A systematic review and metaanalysis

9 p | 10 | 1

Lung fibrotic tenascin-C upregulation is associated with other extracellular matrix proteins and induced by TGFβ1

9 p | 8 | 1

Administration of nintedanib after discontinuation for acute exacerbation of idiopathic pulmonary fibrosis: A case report

4 p | 9 | 1